A61K8/671

PHARMACEUTICAL COMPOSITIONS
20220124572 · 2022-04-21 · ·

A composition including a synergistic combination of a vitamin D3 or a derivative or precursor thereof and hyaluronic acid or derivate thereof encapsulated in a lipid based colloidal carrier system (preferably lipid based vesicles such as liposomes, niosomes, tranferosomes) and topical formulations thereof, as well as their use in the prevention and/or treatment of inflamed skin and mucous membrane, especially in the prevention and/or treatment of skin photodamage, in particular in the prevention and/or treatment of skin erythema (skin inflammation) and actinic keratosis, as well non melanoma skin cancer.

Hair Loss Treatment Composition
20220118043 · 2022-04-21 ·

This present invention relates to a hair treatment spray which be used to promote hair strength, durability, and growth. The hair treatment spray comprises of all-natural products including grapeseed oil, watermelon extract, orange extract, pineapple extract, lime oil, Vitamins A, C, and E, and more, and is free from harmful chemicals and parabens which inhibits from additional hair damage due to conventional hair care products. The hair treatment spray can be used by people of all ages and for any hair color and type, which reconstructs and rejuvenates the hair follicle and scalp in order to restore hair growth and inhibit further hair loss

COMPOSITION FOR PENETRATING SUGAR BASED DELIVERY SYSTEM

A water based composition contains a sugar based delivery system, coemulsifiers, a positively charged molecule, oil, optional auxiliary materials, and optional lipophilic active ingredients. The composition is encapsulated to be used in personal care products including cosmetics. The composition is penetrating into the skin and is, depending on the active included, able to stabilize the substance and reduce its irritation potential.

HIGH-CONTENT AND SUSTAINED-RELEASE RETINOID CAPSULE, AND COMPOSITION FOR REDUCING WRINKLES, CONTAINING SAME

Provided is a composition for improving wrinkles including a high-content/sustained-release retinoid capsule. The high-content/sustained-release retinoid capsule according to the presently claimed subject matter can minimize skin side effects and maximize wrinkle improvement effects by significantly increasing the retinoid content in the capsule and stability and controlling the release rate.

METHOD OF MANUFACTURING SPRAY-DRIED POWDERS
20210360951 · 2021-11-25 ·

The present invention relates to a method of manufacturing spray-dried powders. During the process, a solvent is used. The process is done batchwise such that the emulsification mass ratio is low when removal of the solvent is started. Preferred solvents are isopropyl acetate and ethyl acetate. The invention also relates to a set-up to run the inventive process at industrial scale.

Skin care composition and method of making a skin care composition

A method for managing a skin care system. The skin care system includes circuitry to receive skin information from a user. The circuitry determines treatable skin conditions based on the skin information. The skin care system generates severity information and cosmetic formulation compatibility information based on the treatable skin conditions. The skin care system is further able to virtually display user-specific compatible cosmetic formulations based on at least one parameter associated with the severity information and cosmetic formulation compatibility.

THREE-STEP PROCESS FOR MIMICKING PLASTIC SURGERY RESULTS
20220015986 · 2022-01-20 ·

A three-step process performs, with a derma roller, a plurality of movements along an area of intended rejuvenation of a human user. Furthermore, the three-step process applies, subsequent to the derma roller performance, a chemical compound to one or more patches of skin at the area of intended rejuvenation. Finally, the three-step process emits, subsequent to the application of the chemical compound, light toward the area of intended rejuvenation. The three-step process may be customized to a user based on a variety of factors (e.g., area of intended rejuvenation, age, skin sensitivity, or the like).

N-acyldipeptide derivatives and their uses

Methods of treating aging related skin changes and of increasing skin thickness with topical administration of N-acyldipeptide derivatives are described. Compositions comprising N-acyldipeptide derivatives, are therapeutically effective for increasing skin thickness, and for treating extrinsic and intrinsic aging and aging related skin changes, such as fine lines, wrinkles, photoaging, hyperpigmentation, laxity, age spots, lentigines, mottled skin, and cellulite.

SYSTEMS AND METHODS FOR TREATING AND/OR PREVENTING ACNE
20210353520 · 2021-11-18 · ·

The present invention generally relates to skin care and, in particular, to systems and methods for treating and/or preventing acne. Acne is believed to be caused by a combination of factors, including Propionibacterium acnes bacteria, excess sebum production, and inflammation from the immune response (e.g., in response to P. acnes). Certain aspects of the invention are thus directed to one or more compositions that collectively target these factors, although it should be understood that a single composition may target more than one factor at a time. For instance, in one set of embodiments, a treatment may include a first composition that cleans the skin, a second composition that contains growth inhibitor of P. acnes (e.g., for use during the day), and a third composition that inhibits sebum production (e.g., for use during the night). One or more of these may contain other components, such as anti-inflammatory agents, moisturizers, topical anti-microbial agents (e.g., salicylic acid), or the like. Other aspects are generally directed to methods of making or use of such compositions, kits including such compositions, or the like.

Retinoids and epidermal stimulants
11173103 · 2021-11-16 · ·

A novel lysophospholipid concentrate produced by a process comprising the steps of combining (i) a de-oiled lecithin and (ii) from about 0.5 to about 2% of an enzyme with PLA2 activity. The lysophospholipid concentrate is a pourable, homogenous mixture/solution at or about room temperature with has no significant visible precipitate that (a) has an HLB of greater than 12, (b) contains greater than about 20% lysophosphatidylcholine, and (c) contains greater than about 10% lysophosphatidic acid or an LPA-mimetic. Novel low-urea retinoate compounds produced by the reaction of (a) retinoic acid and (b) one or both of glycerine and/or a monoacylglyceride in the presence of a carbodiimide coupling agent, and preferably in the presence of p-toluene sulfonic acid. The low-urea retinoate is a pourable, homogenous mixture/solution at or about room temperature with no significant visible precipitate.